Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: A new host defense mechanism

FASEB Journal

Volumn 20, Issue 10, 2006, Pages

  Rumbaugh, J ^a   Turchan Cholewo, J ^b   Galey, D ^a   St Hillaire, C ^a   Anderson, C ^a   Conant, K ^a   Nath, A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c Pathology 509 ^*  (United States)

Author keywords

Human; Immunodeficiency diseases; Neuroimmunology; Neurotoxicity; Viral

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ELECTROPHORESIS; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; WESTERN BLOTTING; CELL CULTURE; CELL MEMBRANE POTENTIAL; CYTOLOGY; DEMENTIA; DRUG EFFECT; FETUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOLOGY; LONG TERMINAL REPEAT; METABOLISM; MITOCHONDRIAL MEMBRANE; NERVE CELL; PATHOLOGY; PROTEIN BINDING; VIROLOGY;

CELLS, CULTURED; DEMENTIA; FETUS; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HUMANS; IMMUNITY; MATRIX METALLOPROTEINASE 1; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; NEURONS; PROTEIN BINDING; TRANS-ACTIVATION (GENETICS);

EID: 33845625199     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-5619fje     Document Type: Article

References (66)

1. McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M., McArthur, J. H., Selnes, O. A., Jacobson, L. P., et al. (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43, 2245-2252
2. Levy, R. M., Bredesen, D. E., and Rosenblum, M. L. (1985) Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 62, 475-495
3. Neuenburg, J. K., Brodt, H. R., Herndier, B. G., Bickel, M., Bacchetti, P., Price, R. W., Grant, R. M., and Schlote, W. (2002) HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31, 171-177
4. Sacktor, N. (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 8 Suppl. 2, 115-121
5. Dore, G. J., McDonald, A., Li, Y., Kaldor, J. M., and Brew, B. J. (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. Aids 17, 1539-1545
6. McArthur, J. C., Haughey, N., Gartner, S., Conant, K., Pardo, C., Nath, A., and Sacktor, N. (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 9, 205-221
7. Turchan, J., Pocernich, C. B., Gairola, C., Chauhan, A., Schifitto, G., Butterfield, D. A., Buch, S., Narayan, O., Sinai, A., Geiger, J., Berger, J. R., Elford, H., and Nath, A. (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60, 307-314
8. Libby, R. T., Lavallee, C. R., Balkema, G. W., Brunken, W. J., and Hunter, D. D. (1999) Disruption of laminin beta2 chain production causes alterations in morphology and function in the CNS. J. Neurosci. 19, 9399-9411
9. Patton, B. L., Chiu, A. Y., and Sanes, J. R. (1998) Synaptic laminin prevents glial entry into the synaptic cleft. Nature 393, 698-701
10. Nichol, K. A., Schulz, M. W., and Bennett, M. R. (1995) Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: neuroprotective properties of glutamate and chondroitin sulfate proteoglycan. Brain Res. 697, 1-16
11. Bozzo, C., Bellomo, G., Silengo, L., Tarone, G., and Altruda, F. (1997) Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp. Cell Res. 237, 326-337
12. Masliah, E., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Wiley, C. A., Mallory, M., Achim, C. L., McCutchan, J. A., Nelson, J. A., Atkinson, J. H., and Grant, I. (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann. Neurol. 42, 963-972
13. Zhang, K., McQuibban, G. A., Silva, C., Butler, G. S., Johnston, J. B., Holden, J., Clark-Lewis, I., Overall, C. M., and Power, C. (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6, 1064-1071
14. Conant, K., St Hillaire, C., Nagase, H., Visse, R., Gary, D., Haughey, N., Anderson, C., Turchan, J., and Nath, A. (2004) MMP-1 interacts with neuronal integrins and stimulates dephosphorylation of Akt. J. Biol. Chem. 279, 8056-8062
15. Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., and Lipton, S. A. (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186-1190
16. Coussens, L. M., Fingleton, B., and Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392
17. McQuibban, G. A., Gong, J. H., Tam, E. M., McCulloch, C. A., Clark-Lewis, I., and Overall, C. M. (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206
18. Chauhan, A., Turchan, J., Pocernich, C., Bruce-Keller, A., Roth, S., Butterfield, D. A., Major, E. O., and Nath, A. (2003) Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278, 13512-13519
19. Malim, M. H., and Cullen, B. R. (1991) HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65, 241-248
20. Tardieu, M., Hery, C., Peudenier, S., Boespflug, O., and Montagnier, L. (1992) Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann. Neurol. 32, 11-17
21. Johnston, J. B., Zhang, K., Silva, C., Shalinsky, D. R., Conant, K., Ni, W., Corbett, D., Yong, V. W., and Power, C. (2001) HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann. Neurol. 49, 230-241
22. Turchan, J., Anderson, C., Hauser, K. F., Sun, Q., Zhang, J., Liu, Y., Wise, P. M., Kruman, I., Maragos, W., Mattson, M. P., Booze, R., and Nath, A. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2, 3
23. Nath, A. (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186 Suppl. 2, S193-S198
24. Kim, T. A., Avraham, H. K., Koh, Y. H., Jiang, S., Park, I. W., and Avraham, S. (2003) HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J. Immunol. 170, 2629-2637
25. Liu, X., Jana, M., Dasgupta, S., Koka, S., He, J., Wood, C., and Pahan, K. (2002) Human immunodeficiency virus type-1 (HIV-1) Tat induces nitric oxide synthase in human astroglia. J. Biol. Chem. 277, 3912-39319
26. Polazzi, E., Levi, G., and Minghetti, L. (1999) Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J. Neuropathol. Exp. Neurol. 58, 825-831
27. Yong, V. W., Krekoski, C. A., Forsyth, P. A., Bell, R., and Edwards, D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 75-80
28. Ma, M., and Nath, A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71, 2495-2499
29. Magnuson, D. S., Knudsen, B. E., Geiger, J. D., Brownstone, R. M., and Nath, A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373-380
30. Olsen, C., Rustad, A., Fonnum, F., Paulsen, R. E., and Hassel, B. (1999) 3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro. Brain Res. 850, 144-149
31. Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., and Geiger, J. D. (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47, 186-194
32. Nath, A., Psooy, K., Martin, C., Knudsen, B., Magnuson, D. S., Haughey, N., and Geiger, J. D. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70, 1475-1480
33. Weiss, J. M., Nath, A., Major, E. O., and Berman, J. W. (1999) HIV-Tat induces MCP-1 mediated monocyte transmigration and up-regulates CCR5 expression on human monocytes. J. Immunol. 163, 2953-2959
34. Kruman, I., Nath, A., and Mattson, M. P. (1998) HIV protein Tat induces apoptosis by a mechanism involving mitochondrial calcium overload and caspase activation. Exp. Neurol. 154, 276-288
35. New, D. R., Ma, M., Epstein, L. G., Nath, A., and Gelbard, H. A. (1997) Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3, 168-173
36. Kutsch, O., Oh, J., Nath, A., and Benveniste, E. N. (2000) Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74, 9214-9221
37. Chen, P., Mayne, M., Power, C., and Nath, A. (1997) The Tat protein of HIV-1 induces tumor necrosis factor-α production: implications for HIV associated neurological diseases. J. Biol. Chem. 272, 22385-22388
38. Langford, D., Sanders, V. J., Mallory, M., Kaul, M., and Masliah, E. (2002) Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis. J. Neuroimmunol. 127, 115-126
39. McManus, C. M., Weidenheim, K., Woodman, S. E., Nunez, J., Hesselgesser, J., Nath, A., and Berman, J. W. (2000) Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am. J. Pathol. 156, 1441-1453
40. Vos, C. M., Sjulson, L., Nath, A., McArthur, J. C., Pardo, C. A., Rothstein, J., and Conant, K. (2000) Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures. Exp. Neurol. 163, 324-330
41. Nath, A., Hauser, K. F., Wojna, V., Booze, R. M., Maragos, W., Prendergast, M., Cass, W., and Turchan, J. T. (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31 Suppl. 2, S62-S69
42. Bansal, A. K., Mactutus, C. F., Nath, A., Maragos, W., Hauser, K. F., and Booze, R. M. (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res. 879, 42-49
43. Flora, G., Lee, Y. W., Nath, A., Hennig, B., Maragos, W., and Toborek, M. (2003) Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp. Neurol. 179, 60-70
44. Gurwell, J. A., Nath, A., Sun, Q., Zhang, J., Martin, K. M., Chen, Y., and Hauser, K. F. (2001) Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102, 555-563
45. Maragos, W. F., Young, K. L., Turchan, J. T., Guseva, M., Pauly, J. R., Nath, A., and Cass, W. A. (2002) Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J. Neurochem. 83, 955-963
46. Wang, P., Barks, J. D., and Silverstein, F. S. (1999) Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Neuroscience 88, 585-597
47. Masliah, E., Ge, N., Achim, C. L., Hansen, L. A., and Wiley, C. A. (1992) Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51, 585-593
48. Fox, L., Alford, M., Achim, C., Mallory, M., and Masliah, E. (1997) Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56, 360-368
49. Gartner, S. (2000) HIV infection and dementia. Science 287, 602-604
50. Nath, A. (1999) Pathobiology of HIV dementia. Sem. Neurol. 19, 113-128
51. Nath, A., and Geiger, J. D. (1998) Neurobiological Aspects of HIV infections: neurotoxic mechanisms. Prog. Neurobiol. 54, 19-33
52. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R., Wingfield, P., and Gallo, R. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type-1 Tat protein on cell growth and viral replication. J. Virol. 67, 277-287
53. Banks, W. A., Robinson, S. M., and Nath, A. (2005) Permeability of the blood-brain barrier to HIV-1 Tat. Exp. Neurol. 193, 218-227
54. Checler, F., and Vincent, B. (2002) Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 25, 616-620
55. Chung, K. K., Dawson, V. L., and Dawson, T. M. (2001) The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci. 24, S7-S14
56. Tikhonov, I., Ruckwardt, T. J., Berg, S., Hatfield, G. S., and David Pauza, C. (2004) Furin cleavage of the HIV-1 Tat protein. FEBS Lett. 565, 89-92
57. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., and Parks, W. C. (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113-117
58. Liu, Y., Dammann, C., and Bhattacharyya, M. K. (2001) The matrix metalloproteinase gene GmMMP2 is activated in response to pathogenic infections in soybean. Plant Physiol. 127, 1788-1797
59. Culley, F. J., Brown, A., Conroy, D. M., Sabroe, I., Pritchard, D. I., and Williams, T. J. (2000) Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J. Immunol. 165, 6447-6453
60. Gelbard, H. A. (1999) Neuroprotective strategies for HIV-1-associated neurologic disease. Ann. N. Y. Acad. Sci. 890, 312-313
61. Sato, H., and Seiki, M. (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405
62. Sasaguri, Y., Murahashi, N., Sugama, K., Kato, S., Hiraoka, K., Satoh, T., Isomoto, H., and Morimatsu, M. (1994) Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab. Invest. 71, 261-269
63. Hautamaki, R. D., Kobayashi, D. K., Senior, R. M., and Shapiro, S. D. (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277, 2002-2004
64. Lukes, A., Mun-Bryce, S., Lukes, M., and Rosenberg, G. A. (1999) Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol. Neurobiol. 19, 267-284
65. Campbell, I. L., and Pagenstecher, A. (1999) Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic. Trends Neurosci. 22, 285-287
66. Montaner, J., Alvarez-Sabin, J., Molina, C. A., Angles, A., Abilleira, S., Arenillas, J., and Monasterio, J. (2001) Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32, 2762-2767